Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;277(4):406-25.
doi: 10.1111/joim.12287. Epub 2014 Aug 1.

Heart failure and Alzheimer's disease

Affiliations
Review

Heart failure and Alzheimer's disease

P Cermakova et al. J Intern Med. 2015 Apr.

Abstract

It has recently been proposed that heart failure is a risk factor for Alzheimer's disease. Decreased cerebral blood flow and neurohormonal activation due to heart failure may contribute to the dysfunction of the neurovascular unit and cause an energy crisis in neurons. This leads to the impaired clearance of amyloid beta and hyperphosphorylation of tau protein, resulting in the formation of amyloid beta plaques and neurofibrillary tangles. In this article, we will summarize the current understanding of the relationship between heart failure and Alzheimer's disease based on epidemiological studies, brain imaging research, pathological findings and the use of animal models. The importance of atherosclerosis, myocardial infarction, atrial fibrillation, blood pressure and valve disease as well as the effect of relevant medications will be discussed.

Keywords: Alzheimer′s disease; dementia; heart failure; neurocardiology; neurovascular unit.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The neurovascular unit, amyloid beta clearance and formation of amyloid beta plaques. The blood–brain barrier is composed of endothelial cells supported by a basement membrane and astrocytic feet. The blood–brain barrier represents an important part of a functional structure known as the neurovascular unit, which also includes pericytes and microglia. Amyloid beta is cleared by transcytosis through the cells of the blood–brain barrier and by phagocytosis by microglia. Disruption of the neurovascular unit is characterized by dysfunctional endothelial cells with abnormal intercellular connections, thickening and rupture of the basement membrane, swelling of astrocytic end feet and activated pericytes and microglial cells. The breakdown of the blood–brain barrier inhibits amyloid beta clearance via transcytosis. Activated microglia are not able to phagocytose its excess which results in accumulation of amyloid beta plaques.
Figure 2
Figure 2
Model of the relationship between heart failure and Alzheimer′s disease. This model shows the possible direct and indirect pathways of the contribution of heart failure to the development of Alzheimer′s disease. Low cardiac output may directly lead to reduced cerebral blood flow. Neurohormonal activation, inflammation and microvascular dysfunction may indirectly contribute to impaired perfusion and therefore insufficient oxygenation of the brain. Hypoxia induces hyperphosphorylation of tau protein and expression of beta secretase which cleaves amyloid precursor protein. In addition, insufficient blood supply causes disruption of cells comprising the neurovascular unit and induces oxidative stress.
Figure 3
Figure 3
Schematic diagram of the complex relationship between heart failure and Alzheimer′s disease.

Comment in

Similar articles

Cited by

References

    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.e2. - PubMed
    1. Wimo A, Jonsson L, Bond J, Prince M, Winblad B Alzheimer Disease International. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9:1–11.e3. - PubMed
    1. Wallin K, Bostrom G, Kivipelto M, Gustafson Y. Risk factors for incident dementia in the very old. Int Psychogeriatr. 2013;25:1135–43. - PubMed
    1. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–51. - PMC - PubMed
    1. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62:1556–60. - PubMed

Publication types